1-4 of 4
S. Strober
Close
Sort by
Journal Articles

Outcomes Following Allogeneic Hematopoietic Cell Transplantation (HCT) Using Non-Myeloablative Conditioning with Total Lymphoid Irradiation (TLI) and Anti-Thymocyte Globulin (ATG) Confirm a Low Incidence of Graft Versus Host Disease (GVHD) with Retained Anti-Tumor Activity

Holbrook Kohrt, MD, Brit Turnbull, PhD, G. Laport, MD, D. Miklos, MD, PhD, J. Shizuru, MD, PhD, L. Johnston, MD, S. Arai, MD, W. K. Weng, MD, PhD, J. Benjamin, MD, PhD, K. Blume, MD, R. Negrin, MD, P. Lavori, PhD, S. Strober, MD, R. Lowsky, MD
Journal: Blood
Blood (2008) 112 (11): 3310.
https://doi.org/10.1182/blood.V112.11.3310.3310
Published: 2008
Journal Articles

Rituximab Infusion Two Months after Nonmyeloablative Transplantation Maintains B-Cell Disease Control with Minimal GVHD.

Sally Arai, B. Sahaf, C. Jones, James Zehnder, Robert Lowsky, S. Strober, Judith Shizuru, Robert Negrin, Laura Johnston, Ginna Laport, Keith Goldstein, Janice (Wes) Brown, David Miklos
Journal: Blood
Blood (2006) 108 (11): 2907.
https://doi.org/10.1182/blood.V108.11.2907.2907
Published: 2006
Journal Articles

Haploidentical Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation (HCT) Using Total Lymphoid Irradiation (TLI) and Anti-Thymocyte Globulin (ATG) Conditioning Protects Against Acute Graft Versus Host Disease (GVHD).

R. Lowsky, K. Heydari, B. Sahaf, J. Shizuru, G. Laport, L. Johnston, K. Stockerl-Goldstein, S. Arai, D. Miklos, K. Blume, L. Herzenberg, R. Negrin, S. Strober
Journal: Blood
Blood (2005) 106 (11): 2904.
https://doi.org/10.1182/blood.V106.11.2904.2904
Published: 2005
Journal Articles

T-cell subsets and suppressor cells in human bone marrow

IG Schmidt-Wolf, S Dejbakhsh-Jones, N Ginzton, P Greenberg, S Strober
Journal: Blood
Blood (1992) 80 (12): 3242–3250.
https://doi.org/10.1182/blood.V80.12.3242.3242
Published: 1992